No results for ‘’
Shree Pacetronix Ltd
₹184.65
(3.45%)
Fri, 25 Sept 2026, 07:58 pm
Health Technology
Medical Specialties
24.5KShree Pacetronix Price to Cash Flow Ratio
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 52.50 | 87.50 | 0 | 0 | 46.81 | 17.08 | 0 | 0 | 0 | 34.27 | 32.77 | 18.20 | 78.44 | 9.38 | 10.78 | 16.27 | 29.91 |
| Price to book ratio | 1.89 | 2.58 | 2.72 | 2.13 | 1.56 | 0.74 | 1.59 | 1.09 | 0.74 | 0.90 | 0.89 | 0.80 | 0.76 | 1.17 | 3.69 | 4.24 | 1.63 |
| Price to sales ratio | 1.73 | 2.34 | 2.41 | 1.54 | 1.22 | 0.51 | 1.26 | 0.76 | 0.51 | 0.67 | 0.64 | 0.49 | 0.55 | 0.79 | 1.73 | 2.48 | 1.33 |
| Price to cash flow ratio | 28.43 | 0 | 18.63 | 185.86 | 17.82 | 6.71 | 149.43 | 5.64 | 92.33 | 5.63 | 274.22 | 2.27 | 5.43 | 4.84 | 23.16 | 0 | 0 |
| Enterprise value | 11.2Cr | 16.53Cr | 16.25Cr | 13.01Cr | 10.07Cr | 5.95Cr | 10.75Cr | 7.24Cr | 6.13Cr | 6.68Cr | 8.09Cr | 7.12Cr | 6.59Cr | 8.63Cr | 36.47Cr | 58.12Cr | 26.39Cr |
| Enterprise value to EBITDA ratio | 14.47 | 19.88 | 30.84 | 13.46 | 8.27 | 4.27 | 10.76 | 6.75 | 11.28 | 7.24 | 10.15 | 5.93 | 6.99 | 4.85 | 6.57 | 9.74 | 11.08 |
| Debt to equity ratio | 0.38 | 0.61 | 0.62 | 0.56 | 0.50 | 0.40 | 0.53 | 0.38 | 0.56 | 0.58 | 0.75 | 0.61 | 0.58 | 0.49 | 0.23 | 0.33 | 0.37 |
| Return on equity % | 0 | 2.96 | -4.54 | 0.03 | 3.36 | 4.42 | -1.14 | -1.65 | -6.53 | 2.68 | 2.76 | 4.47 | 0.97 | 13.29 | 41.29 | 29.98 | 5.63 |
Shree Pacetronix Ltd Price to Cash Flow Ratio
The Shree Pacetronix Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Shree Pacetronix Ltd's valuation, profitability, and overall financial performance. Tracking the Shree Pacetronix Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Shree Pacetronix Ltd (NSE: , BSE: 527005) is currently trading at ₹184.65, with a market capitalization of ₹71.71Cr. As a leading company in the Health technology sector and Medical specialties industry, monitoring the Shree Pacetronix Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Shree Pacetronix Ltd Price to Cash Flow Ratio Current Value
The current Shree Pacetronix Ltd Price to Cash Flow Ratio stands at 0.
The Shree Pacetronix Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Shree Pacetronix Ltd Price to Cash Flow Ratio Historical Trend
The Shree Pacetronix Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 23.16
- 2021: 4.84
- 2020: 5.43
The decline in Shree Pacetronix Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Shree Pacetronix Ltd Price to Cash Flow Ratio Indicates for Investors
The Shree Pacetronix Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Shree Pacetronix Ltd Price to Cash Flow Ratio Analysis Summary
The Shree Pacetronix Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Shree Pacetronix Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Shree Pacetronix Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.